A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)

NCT02731131 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis D, Chronic

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Ribavirin

Sponsor

Hoffmann-La Roche